BiliaryTractCancer near Astoria, NY

Biography: Tomoaki Kato, MD, is a noted pioneer in multiple-organ transplantation, pediatric and adult liver transplantation. Dr. Kato is Surgical Director of Adult and Pediatric Liver and Intestinal Transplantation at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center and is a professor of surgery at Columbia University College of Physicians and Surgeons. Dr. Kato is known for unique and innovative surgeries for adults and children, including a six-organ transplant; a procedure called APOLT (auxiliary partial orthotopic liver transplantation) that resuscitates a failing liver by attaching a partial donor liver, making immunosuppressant drugs unnecessary and the first successful human partial bladder transplantation involving the transplant of two kidneys together with ureters connected to a patch of the donor bladder. In a highly publicized case, he led the first reported removal and re-implantation, or auto-transplantation, of six organs to excise a hard-to-reach abdominal tumor. Previously the director of pediatric liver and gastrointestinal transplant and professor of clinical surgery at the University of Miami School of Medicine, Dr. Kato received his medical degree from the Osaka University Medical School in Japan and received his residency training in surgery at Osaka University Hospital and Itami City Hospital in Hyogo, Japan. He completed a clinical fellowship in transplantation at the University of Miami/Jackson Memorial Hospital, in Miami, Florida, where he was subsequently appointed to the surgical faculty in 1997, and promoted to full professor in 2007. He served as a surgeon and senior leader of the liver and transplantation center at Miami's Jackson Memorial Hospital, beginning in 1997, and at University of Miami Hospital (previously Cedars Medical Center), beginning in 2004. Dr. Kato is a member of numerous professional and honorary organizations, and the author or co-author of more than 180 scientific papers in peer-reviewed journals.ResourcesFor more information, visit the Center for Liver Disease and TransplantationIf you need assistance in Chinese (Mandarin & Cantonese), please call 646-317-6325 or, visit the Columbia Liver Asian Outreach Office (English | Mandarin

Biography: Myron M. Studner Professor of Cancer Research and Professor of Medicine and Epidemiology at Columbia University, Associate Director for Population Science, Leader of the Prevention, Control, and Disparities Program for the Herbert Irving Comprehensive Cancer Center at Columbia, and Co-Director of the Cancer Prevention Center of New York Presbyterian Hospital Dr. Neugut is a medical oncologist with a particular interest in gastroIntestinal tract cancers, especially of colorectal and gasteric cancers. Under the auspices of Columbia's MD/PhD program, he received his MD and a PhD in Pathobiology in 1977. He did his training in Internal Medicine at the Albert Einstein College of Medicine and fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center. He returned to Columbia University as an Andrew Mellon Fellow in Epidemiology and Medicine to obtain an MPH in Epidemiology in 1983. Dr. Neugut then joined the faculty at Columbia University with appointments in Medicine and Epidemiology. As both a practicing medical oncologist and cancer epidemiologist, Dr. Alfred Neugut's major interests have been on GI tract cancers, notably the epidemiology of colorectal adenomas and cancer, as well as colonoscopic screening. He serves as co-principal investigator of the Long Island Breast Cancer Study Project, a large multi-center effort to explore environmental causes of breast cancer on Long Island. Most recently, his efforts have focused on more clinical topics, such as the epidemiology of second malignancies and the use of chemotherapy and radiation therapy among elderly cancer patients. Dr. Neugut focuses a great deal on racial disparities in incidence and survival from cancer and, in particular, variations across subgroups of people of African descent. He leads two large training grants in cancer-related population sciences that together fund 15 pre and postdoctoral trainees in cancer epidemiology, biostatistics, and environmental health sciences, and serves as a mentor to a number of junior faculty.

Biography: Dr. Krzysztof Misiukiewicz, MD is a Hematology Specialist who practices in New York, NY. He is 52 years old. Dr. Krzysztof Misiukiewicz, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Hanna Irie, MD is a Hematology Specialist who practices in New York, NY. She is 55 years old. Dr. Hanna Irie, MD is affiliated with Mount Sinai Hospital.

Biography: Dr. Catherine Shu isthe Price Family Associate Professor of Medicine anda board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, but has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she devotes part of her research effort to patients with targetable mutations, helping to determine the best sequence of treatments. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients.

Biography: Dr. Sundar Jagannath, MB BS is a Hematology Specialist who practices in New York, NY. He is 74 years old and has been practicing for 49 years. Dr. Sundar Jagannath, MB BS is affiliated with Mount Sinai Hospital and Mount Sinai Morningside.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience We are devoted to providing services that are patient centered and compassionate and care for you as a person nbsp;

Biography: Dr. Accordino graduated from The Pennsylvania State University with a bachelor of science in Pre-medicine with minors in Health Policy and Administration and Biology. She completed her medical degree at The Pennsylvania State University College of Medicine. While in medical school she was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. She completed her Internal Medicine residency at Weill Cornell Medical Center and her Medical Hematology/Oncology fellowship at Columbia University Medical Center, where she served as Chief Fellow. During that time, she was awarded a Conquer Cancer Foundation of the American Society of Clinical Oncology Young Investigator Award and Merit Award. She also served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in quality improvement and health outcomes research. Upon fellowship graduation she became an Assistant Professor of Medicine within the Division of Hematology/Oncology at Columbia University. Since her faculty appointment she has received grant funding from multiple agencies including: The American Society of Clinical Oncology, The HOPE Foundation, The Breast Cancer Research Foundation, The American Cancer Society, and the National Institutes of Health/National Cancer Institute. Dr. Accordino is currently involved in patient care, clinical research, education, and quality improvement. Dr. Accordino's research aims to improve the quality and delivery of cancer care, and cancer survivorship. Dr. Accordino participates in clinical trials at the local, national, and international level. She also has experience leading multicenter cancer trials through the SWOG Cooperative Group. The overall goal of her research is to improve quality and outcomes within oncology.